North America Pharmacogenomics Market (2025-2031) | Outlook, Opportunities, Value, Segmentation, Pricing Analysis, Revenue, Trends, Supply, Industry, Consumer Insights, Investment Trends, Segments, Forecast, Strategy, Drivers, Analysis, Share, Demand, Growth, Challenges, Size, Restraints, Competitive, Competition, Companies, Strategic Insights

Name: North America Pharmacogenomics Market (2025 - 2031) | Trends, Outlook & Forecast
Creator: 6Wresearch
License: https://www.6wresearch.com/privacy-policy
Keywords: Pharmacogenomics Market, North America Pharmacogenomics Market, North America Pharmacogenomics Market Revenues, North America Pharmacogenomics Market Share, North America Pharmacogenomics Market Size, North America Pharmacogenomics Market Outlook, North America Pharmacogenomics Market Report, North America Pharmacogenomics Market Competition, North America Pharmacogenomics Market Overview, North America Pharmacogenomics Market Trends, North America Pharmacogenomics Market Forecast

Market Forecast by Countries (United States (US), Canada, Rest of North America), By Technology (Polymerase Chain Reaction, Microarray, DNA Sequencing, Mass Spectrometry, Electrophoresis, Others), By Application (Oncology, Infectious Diseases, Cardiovascular Diseases, Neurological Diseases, Psychiatry, Pain Management, Others), By End User (Hospitals and Clinics, Academic and Research Institutes) And Competitive Landscape

Product Code: ETC13167507	Publication Date: Apr 2025	Product Type: Market Research Report
Publisher: 6Wresearch	No. of Pages: 150	No. of Figures: 55	No. of Tables: 32

Key Highlights of the Report:

North America Pharmacogenomics Market Outlook
Market Size of North America Pharmacogenomics Market, 2024
Forecast of North America Pharmacogenomics Market, 2031
Historical Data and Forecast of North America Pharmacogenomics Revenues & Volume for the Period 2021 - 2031
North America Pharmacogenomics Market Trend Evolution
North America Pharmacogenomics Market Drivers and Challenges
North America Pharmacogenomics Price Trends
North America Pharmacogenomics Porter's Five Forces
North America Pharmacogenomics Industry Life Cycle
Historical Data and Forecast of North America Pharmacogenomics Market Revenues & Volume By Technology for the Period 2021 - 2031
Historical Data and Forecast of North America Pharmacogenomics Market Revenues & Volume By Polymerase Chain Reaction for the Period 2021 - 2031
Historical Data and Forecast of North America Pharmacogenomics Market Revenues & Volume By Microarray for the Period 2021 - 2031
Historical Data and Forecast of North America Pharmacogenomics Market Revenues & Volume By DNA Sequencing for the Period 2021 - 2031
Historical Data and Forecast of North America Pharmacogenomics Market Revenues & Volume By Mass Spectrometry for the Period 2021 - 2031
Historical Data and Forecast of North America Pharmacogenomics Market Revenues & Volume By Electrophoresis for the Period 2021 - 2031
Historical Data and Forecast of North America Pharmacogenomics Market Revenues & Volume By Others for the Period 2021 - 2031
Historical Data and Forecast of United States (US) Pharmacogenomics Market Revenues & Volume By Technology for the Period 2021 - 2031
Historical Data and Forecast of United States (US) Pharmacogenomics Market Revenues & Volume By Polymerase Chain Reaction for the Period 2021 - 2031
Historical Data and Forecast of United States (US) Pharmacogenomics Market Revenues & Volume By Microarray for the Period 2021 - 2031
Historical Data and Forecast of United States (US) Pharmacogenomics Market Revenues & Volume By DNA Sequencing for the Period 2021 - 2031
Historical Data and Forecast of United States (US) Pharmacogenomics Market Revenues & Volume By Mass Spectrometry for the Period 2021 - 2031
Historical Data and Forecast of United States (US) Pharmacogenomics Market Revenues & Volume By Electrophoresis for the Period 2021 - 2031
Historical Data and Forecast of United States (US) Pharmacogenomics Market Revenues & Volume By Others for the Period 2021 - 2031
Historical Data and Forecast of Canada Pharmacogenomics Market Revenues & Volume By Technology for the Period 2021 - 2031
Historical Data and Forecast of Canada Pharmacogenomics Market Revenues & Volume By Polymerase Chain Reaction for the Period 2021 - 2031
Historical Data and Forecast of Canada Pharmacogenomics Market Revenues & Volume By Microarray for the Period 2021 - 2031
Historical Data and Forecast of Canada Pharmacogenomics Market Revenues & Volume By DNA Sequencing for the Period 2021 - 2031
Historical Data and Forecast of Canada Pharmacogenomics Market Revenues & Volume By Mass Spectrometry for the Period 2021 - 2031
Historical Data and Forecast of Canada Pharmacogenomics Market Revenues & Volume By Electrophoresis for the Period 2021 - 2031
Historical Data and Forecast of Canada Pharmacogenomics Market Revenues & Volume By Others for the Period 2021 - 2031
Historical Data and Forecast of Rest of North America Pharmacogenomics Market Revenues & Volume By Technology for the Period 2021 - 2031
Historical Data and Forecast of Rest of North America Pharmacogenomics Market Revenues & Volume By Polymerase Chain Reaction for the Period 2021 - 2031
Historical Data and Forecast of Rest of North America Pharmacogenomics Market Revenues & Volume By Microarray for the Period 2021 - 2031
Historical Data and Forecast of Rest of North America Pharmacogenomics Market Revenues & Volume By DNA Sequencing for the Period 2021 - 2031
Historical Data and Forecast of Rest of North America Pharmacogenomics Market Revenues & Volume By Mass Spectrometry for the Period 2021 - 2031
Historical Data and Forecast of Rest of North America Pharmacogenomics Market Revenues & Volume By Electrophoresis for the Period 2021 - 2031
Historical Data and Forecast of Rest of North America Pharmacogenomics Market Revenues & Volume By Others for the Period 2021 - 2031
Historical Data and Forecast of North America Pharmacogenomics Market Revenues & Volume By Application for the Period 2021 - 2031
Historical Data and Forecast of North America Pharmacogenomics Market Revenues & Volume By Oncology for the Period 2021 - 2031
Historical Data and Forecast of North America Pharmacogenomics Market Revenues & Volume By Infectious Diseases for the Period 2021 - 2031
Historical Data and Forecast of North America Pharmacogenomics Market Revenues & Volume By Cardiovascular Diseases for the Period 2021 - 2031
Historical Data and Forecast of North America Pharmacogenomics Market Revenues & Volume By Neurological Diseases for the Period 2021 - 2031
Historical Data and Forecast of North America Pharmacogenomics Market Revenues & Volume By Psychiatry for the Period 2021 - 2031
Historical Data and Forecast of North America Pharmacogenomics Market Revenues & Volume By Pain Management for the Period 2021 - 2031
Historical Data and Forecast of North America Pharmacogenomics Market Revenues & Volume By Others for the Period 2021 - 2031
Historical Data and Forecast of United States (US) Pharmacogenomics Market Revenues & Volume By Application for the Period 2021 - 2031
Historical Data and Forecast of United States (US) Pharmacogenomics Market Revenues & Volume By Oncology for the Period 2021 - 2031
Historical Data and Forecast of United States (US) Pharmacogenomics Market Revenues & Volume By Infectious Diseases for the Period 2021 - 2031
Historical Data and Forecast of United States (US) Pharmacogenomics Market Revenues & Volume By Cardiovascular Diseases for the Period 2021 - 2031
Historical Data and Forecast of United States (US) Pharmacogenomics Market Revenues & Volume By Neurological Diseases for the Period 2021 - 2031
Historical Data and Forecast of United States (US) Pharmacogenomics Market Revenues & Volume By Psychiatry for the Period 2021 - 2031
Historical Data and Forecast of United States (US) Pharmacogenomics Market Revenues & Volume By Pain Management for the Period 2021 - 2031
Historical Data and Forecast of United States (US) Pharmacogenomics Market Revenues & Volume By Others for the Period 2021 - 2031
Historical Data and Forecast of Canada Pharmacogenomics Market Revenues & Volume By Application for the Period 2021 - 2031
Historical Data and Forecast of Canada Pharmacogenomics Market Revenues & Volume By Oncology for the Period 2021 - 2031
Historical Data and Forecast of Canada Pharmacogenomics Market Revenues & Volume By Infectious Diseases for the Period 2021 - 2031
Historical Data and Forecast of Canada Pharmacogenomics Market Revenues & Volume By Cardiovascular Diseases for the Period 2021 - 2031
Historical Data and Forecast of Canada Pharmacogenomics Market Revenues & Volume By Neurological Diseases for the Period 2021 - 2031
Historical Data and Forecast of Canada Pharmacogenomics Market Revenues & Volume By Psychiatry for the Period 2021 - 2031
Historical Data and Forecast of Canada Pharmacogenomics Market Revenues & Volume By Pain Management for the Period 2021 - 2031
Historical Data and Forecast of Canada Pharmacogenomics Market Revenues & Volume By Others for the Period 2021 - 2031
Historical Data and Forecast of Rest of North America Pharmacogenomics Market Revenues & Volume By Application for the Period 2021 - 2031
Historical Data and Forecast of Rest of North America Pharmacogenomics Market Revenues & Volume By Oncology for the Period 2021 - 2031
Historical Data and Forecast of Rest of North America Pharmacogenomics Market Revenues & Volume By Infectious Diseases for the Period 2021 - 2031
Historical Data and Forecast of Rest of North America Pharmacogenomics Market Revenues & Volume By Cardiovascular Diseases for the Period 2021 - 2031
Historical Data and Forecast of Rest of North America Pharmacogenomics Market Revenues & Volume By Neurological Diseases for the Period 2021 - 2031
Historical Data and Forecast of Rest of North America Pharmacogenomics Market Revenues & Volume By Psychiatry for the Period 2021 - 2031
Historical Data and Forecast of Rest of North America Pharmacogenomics Market Revenues & Volume By Pain Management for the Period 2021 - 2031
Historical Data and Forecast of Rest of North America Pharmacogenomics Market Revenues & Volume By Others for the Period 2021 - 2031
Historical Data and Forecast of North America Pharmacogenomics Market Revenues & Volume By End User for the Period 2021 - 2031
Historical Data and Forecast of North America Pharmacogenomics Market Revenues & Volume By Hospitals and Clinics for the Period 2021 - 2031
Historical Data and Forecast of North America Pharmacogenomics Market Revenues & Volume By Academic and Research Institutes for the Period 2021 - 2031
Historical Data and Forecast of United States (US) Pharmacogenomics Market Revenues & Volume By End User for the Period 2021 - 2031
Historical Data and Forecast of United States (US) Pharmacogenomics Market Revenues & Volume By Hospitals and Clinics for the Period 2021 - 2031
Historical Data and Forecast of United States (US) Pharmacogenomics Market Revenues & Volume By Academic and Research Institutes for the Period 2021 - 2031
Historical Data and Forecast of Canada Pharmacogenomics Market Revenues & Volume By End User for the Period 2021 - 2031
Historical Data and Forecast of Canada Pharmacogenomics Market Revenues & Volume By Hospitals and Clinics for the Period 2021 - 2031
Historical Data and Forecast of Canada Pharmacogenomics Market Revenues & Volume By Academic and Research Institutes for the Period 2021 - 2031
Historical Data and Forecast of Rest of North America Pharmacogenomics Market Revenues & Volume By End User for the Period 2021 - 2031
Historical Data and Forecast of Rest of North America Pharmacogenomics Market Revenues & Volume By Hospitals and Clinics for the Period 2021 - 2031
Historical Data and Forecast of Rest of North America Pharmacogenomics Market Revenues & Volume By Academic and Research Institutes for the Period 2021 - 2031
North America Pharmacogenomics Market - Key Performance Indicators
North America Pharmacogenomics Market - Import Export Trade Statistics
North America Pharmacogenomics Market - Opportunity Assessment By Countries
North America Pharmacogenomics Market - Opportunity Assessment By Technology
North America Pharmacogenomics Market - Opportunity Assessment By Application
North America Pharmacogenomics Market - Opportunity Assessment By End User
North America Pharmacogenomics Market - Top Companies Market Share
North America Pharmacogenomics Market - Top Companies Profiles
North America Pharmacogenomics Market - Comparison of Players in Technical and Operating Parameters
North America Pharmacogenomics Market - Strategic Recommendations

Frequently Asked Questions About the Market Study (FAQs):

How does 6Wresearch market report help businesses in making strategic decisions?

Do you also provide customisation in the market study?

North America Pharmacogenomics Market

1 Executive Summary

2 Introduction

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3 North America Pharmacogenomics Market Overview

3.1 North America Regional Macro Economic Indicators

3.2 North America Pharmacogenomics Market Revenues & Volume, 2021 & 2031F

3.3 North America Pharmacogenomics Market - Industry Life Cycle

3.4 North America Pharmacogenomics Market - Porter's Five Forces

3.5 North America Pharmacogenomics Market Revenues & Volume Share, By Countries, 2021 & 2031F

3.6 North America Pharmacogenomics Market Revenues & Volume Share, By Technology, 2021 & 2031F

3.7 North America Pharmacogenomics Market Revenues & Volume Share, By Application, 2021 & 2031F

3.8 North America Pharmacogenomics Market Revenues & Volume Share, By End User, 2021 & 2031F

4 North America Pharmacogenomics Market Dynamics

4.1 Impact Analysis

4.2 Market Drivers

4.3 Market Restraints

5 North America Pharmacogenomics Market Trends

6 North America Pharmacogenomics Market, 2021 - 2031

6.1 North America Pharmacogenomics Market, Revenues & Volume, By Technology, 2021 - 2031

6.1.1 Overview & Analysis

6.1.2 North America Pharmacogenomics Market, Revenues & Volume, By Polymerase Chain Reaction, 2021 - 2031

6.1.3 North America Pharmacogenomics Market, Revenues & Volume, By Microarray, 2021 - 2031

6.1.4 North America Pharmacogenomics Market, Revenues & Volume, By DNA Sequencing, 2021 - 2031

6.1.5 North America Pharmacogenomics Market, Revenues & Volume, By Mass Spectrometry, 2021 - 2031

6.1.6 North America Pharmacogenomics Market, Revenues & Volume, By Electrophoresis, 2021 - 2031

6.1.7 North America Pharmacogenomics Market, Revenues & Volume, By Others, 2021 - 2031

6.2 North America Pharmacogenomics Market, Revenues & Volume, By Application, 2021 - 2031

6.2.1 Overview & Analysis

6.2.2 North America Pharmacogenomics Market, Revenues & Volume, By Oncology, 2021 - 2031

6.2.3 North America Pharmacogenomics Market, Revenues & Volume, By Infectious Diseases, 2021 - 2031

6.2.4 North America Pharmacogenomics Market, Revenues & Volume, By Cardiovascular Diseases, 2021 - 2031

6.2.5 North America Pharmacogenomics Market, Revenues & Volume, By Neurological Diseases, 2021 - 2031

6.2.6 North America Pharmacogenomics Market, Revenues & Volume, By Psychiatry, 2021 - 2031

6.2.7 North America Pharmacogenomics Market, Revenues & Volume, By Pain Management, 2021 - 2031

6.2.8 North America Pharmacogenomics Market, Revenues & Volume, By Others, 2021 - 2031

6.3 North America Pharmacogenomics Market, Revenues & Volume, By End User, 2021 - 2031

6.3.1 Overview & Analysis

6.3.2 North America Pharmacogenomics Market, Revenues & Volume, By Hospitals and Clinics, 2021 - 2031

6.3.3 North America Pharmacogenomics Market, Revenues & Volume, By Academic and Research Institutes, 2021 - 2031

7 North America Pharmacogenomics Market, By Countries, 2021 - 2031

7.1 Overview & Analysis

7.2 North America Pharmacogenomics Market, Revenues & Volume, By Technology, 2021 - 2031

7.2.1 United States (US) Pharmacogenomics Market, Revenues & Volume, By Technology, 2021 - 2031

7.2.2 Canada Pharmacogenomics Market, Revenues & Volume, By Technology, 2021 - 2031

7.2.3 Rest of North America Pharmacogenomics Market, Revenues & Volume, By Technology, 2021 - 2031

7.3 North America Pharmacogenomics Market Revenues & Volume Share, By Application, 2021 & 2031F

7.3.1 United States (US) Pharmacogenomics Market, Revenues & Volume, By Application, 2021 - 2031

7.3.2 Canada Pharmacogenomics Market, Revenues & Volume, By Application, 2021 - 2031

7.3.3 Rest of North America Pharmacogenomics Market, Revenues & Volume, By Application, 2021 - 2031

7.4 North America Pharmacogenomics Market, Revenues & Volume, By End User, 2021 - 2031

7.4.1 United States (US) Pharmacogenomics Market, Revenues & Volume, By End User, 2021 - 2031

7.4.2 Canada Pharmacogenomics Market, Revenues & Volume, By End User, 2021 - 2031

7.4.3 Rest of North America Pharmacogenomics Market, Revenues & Volume, By End User, 2021 - 2031

8 North America Pharmacogenomics Market Key Performance Indicators

9 North America Pharmacogenomics Market - Export/Import By Countries Assessment

10 North America Pharmacogenomics Market - Opportunity Assessment

10.1 North America Pharmacogenomics Market Opportunity Assessment, By Countries, 2021 & 2031F

10.2 North America Pharmacogenomics Market Opportunity Assessment, By Technology, 2021 & 2031F

10.3 North America Pharmacogenomics Market Opportunity Assessment, By Application, 2021 & 2031F

10.4 North America Pharmacogenomics Market Opportunity Assessment, By End User, 2021 & 2031F

11 North America Pharmacogenomics Market - Competitive Landscape

11.1 North America Pharmacogenomics Market Revenue Share, By Companies, 2022

11.2 North America Pharmacogenomics Market Competitive Benchmarking, By Operating and Technical Parameters

12 Top 10 Company Profiles

13 Recommendations

14 Disclaimer

Africa Pharmacogenomics Market

Global Pharmacogenomics Market

Kenya Pharmacogenomics Market

Kuwait Pharmacogenomics Market

Lebanon Pharmacogenomics Market

Malaysia Pharmacogenomics Market

Mexico Pharmacogenomics Market

Middle East Pharmacogenomics Market

Export potential assessment - trade Analytics for 2030

Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.

By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.

To discover high-growth global markets and optimize your business strategy:

Click Here